These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21970467)

  • 1. Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.
    Andersen F; Viitanen M; Halvorsen DS; Straume B; Engstad TA
    BMC Geriatr; 2011 Oct; 11():58. PubMed ID: 21970467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-dementia drugs and co-medication among patients with Alzheimer's disease : investigating real-world drug use in clinical practice using the Swedish Dementia Quality Registry (SveDem).
    Fereshtehnejad SM; Johnell K; Eriksdotter M
    Drugs Aging; 2014 Mar; 31(3):215-24. PubMed ID: 24497071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail.
    Andersen F; Engstad TA; Straume B; Viitanen M; Halvorsen DS; Hykkerud S; Sjøbrend K
    BMC Med Res Methodol; 2010 Apr; 10():35. PubMed ID: 20429946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
    Laroche ML; Perault-Pochat MC; Ingrand I; Merle L; Kreft-Jais C; Castot-Villepelet A; Durrieu G; Gras V; Guy C; Jean-Pastor MJ; Jonville-Béra AP; Merlet-Chicoine I; Miremont-Salamé G; Nourhashemi F; Charmes JP;
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):952-60. PubMed ID: 23794320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
    Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
    Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.
    Lapi F; Pozzi C; Mazzaglia G; Ungar A; Fumagalli S; Marchionni N; Geppetti P; Mugelli A; Di Bari M
    Drugs Aging; 2009; 26(12):1029-38. PubMed ID: 19929030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
    Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).
    Vidoni ED; Kamat A; Gahan WP; Ourso V; Woodard K; Kerwin DR; Binder EF; Burns JM; Cullum M; Hynan LS; Vongpatanasin W; Zhu DC; Zhang R; Keller JN
    J Alzheimers Dis; 2020; 77(1):175-182. PubMed ID: 32716358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sedative Load in Community-Dwelling Older Adults with Mild-Moderate Alzheimer's Disease: Longitudinal Relationships with Adverse Events, Delirium and Falls.
    Dyer AH; Murphy C; Lawlor B; Kennelly SP;
    Drugs Aging; 2020 Nov; 37(11):829-837. PubMed ID: 32924095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.
    Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R
    Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design.
    Andersen F; Viitanen M; Halvorsen DS; Straume B; Wilsgaard T; Engstad TA
    BMC Neurol; 2012 Jul; 12():59. PubMed ID: 22813231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.
    Imfeld P; Brauchli Pernus YB; Jick SS; Meier CR
    J Alzheimers Dis; 2013; 35(3):565-73. PubMed ID: 23455986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease or other dementia and medical care utilization.
    Eaker ED; Mickel SF; Chyou PH; Mueller-Rizner NJ; Slusser JP
    Ann Epidemiol; 2002 Jan; 12(1):39-45. PubMed ID: 11750239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C; Londos E; Minthon L
    Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of co-morbidity and frailty on the clinical manifestation of patients with Alzheimer's disease.
    Oosterveld SM; Kessels RP; Hamel R; Ramakers IH; Aalten P; Verhey FR; Sistermans N; Smits LL; Pijnenburg YA; van der Flier WM; Olde Rikkert MG; Melis RJ
    J Alzheimers Dis; 2014; 42(2):501-9. PubMed ID: 24898646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing medications of questionable benefit prior to death: a retrospective study on older nursing home residents with and without dementia in Germany.
    Rausch C; Hoffmann F
    Eur J Clin Pharmacol; 2020 Jun; 76(6):877-885. PubMed ID: 32219538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication Use for Comorbidities in People with Alzheimer's Disease: An Australian Population-Based Study.
    Eshetie TC; Nguyen TA; Gillam MH; Kalisch Ellett LM
    Pharmacotherapy; 2019 Dec; 39(12):1146-1156. PubMed ID: 31596509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.
    Jacquin-Piques A; Sacco G; Tavassoli N; Rouaud O; Bejot Y; Giroud M; Robert P; Vellas B; Bonin-Guillaume S
    J Alzheimers Dis; 2016; 49(3):671-80. PubMed ID: 26484903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria.
    Schuler J; Dückelmann C; Beindl W; Prinz E; Michalski T; Pichler M
    Wien Klin Wochenschr; 2008; 120(23-24):733-41. PubMed ID: 19122984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.